163 related articles for article (PubMed ID: 36749492)
1. Cytohesin-4 Upregulation in Glioma-Associated M2 Macrophages Is Correlated with Pyroptosis and Poor Prognosis.
Guan Y; Xu B; Sui Y; Li H; Chen Z; Luan Y; Yang R; Qi W; Guan Q
J Mol Neurosci; 2023 Mar; 73(2-3):143-158. PubMed ID: 36749492
[TBL] [Abstract][Full Text] [Related]
2. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication and immunological characterisation of the ARF-GEF family member CYTH4 in ovarian cancer.
Zhang Q; Wang Q; Wu S; Zhang J
Autoimmunity; 2020 Dec; 53(8):434-442. PubMed ID: 33078956
[TBL] [Abstract][Full Text] [Related]
4. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
Chen J; Chen S; Li B; Zhou S; Lin H
Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
[TBL] [Abstract][Full Text] [Related]
5.
Ma W; Zhang K; Bao Z; Jiang T; Zhang Y
Front Immunol; 2021; 12():659659. PubMed ID: 33936093
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
7. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
[TBL] [Abstract][Full Text] [Related]
8. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis and validation reveal CYTH4 as a potential prognostic biomarker in acute myeloid leukemia.
Wang H; Xiao Y; Zhou W; Li Y
Oncol Lett; 2024 Mar; 27(3):103. PubMed ID: 38298432
[TBL] [Abstract][Full Text] [Related]
10. Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression.
Li L; Wu L; Yin X; Li C; Hua Z
Oxid Med Cell Longev; 2022; 2022():1803544. PubMed ID: 36199426
[TBL] [Abstract][Full Text] [Related]
11. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
12.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
13. A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma.
Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X
J Inflamm Res; 2022; 15():17-32. PubMed ID: 35018108
[TBL] [Abstract][Full Text] [Related]
14. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB
Front Immunol; 2020; 11():606164. PubMed ID: 33408717
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
[TBL] [Abstract][Full Text] [Related]
17. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
18. CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.
Xiao Y; Yang K; Wang Z; Zhao M; Deng Y; Ji W; Zou Y; Qian C; Liu Y; Xiao H; Liu H
Front Surg; 2021; 8():775194. PubMed ID: 35187044
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.
Zhu H; Hu X; Feng S; Gu L; Jian Z; Zou N; Xiong X
Front Immunol; 2022; 13():946692. PubMed ID: 35928818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
